Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 130,000 shares at $50.24 ($6.5M) on 2022-08-04, disclosed to the SEC on 2022-08-08.
Open-market sale of $6.5M CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2020-12-16 | $3.7M | — | Filing → |